De novo methylation is predominantly established by DNMT3A and DNMT3B, although both share function and similar targets, there are specific target regions and genes for each of them9, different functional mechanisms10,11, differential functional results in the same context12 and, there are different expression profiles in cancer for each of DNMTs13. The gene discussed is DNMT3B; the disease is cancer.